Halozyme Therapeutics Inc. trailing returns
Halozyme Therapeutics Inc.'s 10-year return is +22.1% a year (CAGR) (+639.4% cumulative). How Halozyme Therapeutics Inc. (HALO) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through November 17, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
Data provided bySource: Twelve DataTo 2026-11-17. Price return + dividends = total return. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| Cumulative · the change over the window | ||||
| 1 day | -0.5% | +0.0% | -0.5% | — |
| 5 days | -6.8% | +0.0% | -6.8% | -6.8%Nov 17 |
| 1 month | -21.2% | +0.0% | -21.2% | -26.8%Nov 17 |
| YTD | +42.6% | +0.0% | +42.6% | -26.8%Nov 17 |
| Per year (CAGR) · the cumulative total return beneath | ||||
| 1 year | +36.0% | +0.0% | +36.0% CAGR | -26.8%Nov 2026 |
| 5 years | +21.1% | +0.0% | +21.1% CAGR+160.6% total | -49.1%May 2023 |
| 10 years | +22.1% | +0.0% | +22.1% CAGR+639.4% total | -49.1%May 2023 |
| 20 years | +19.6% | +0.0% | +19.6% CAGR35.8x total | -74.3%Dec 2008 |
| Since 2004Since inception (2004) | +14.7% | +0.0% | +14.7% CAGR22.6x total | -74.3%Dec 2008 |
Growth of HALO#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years+21.1%/year · +160.6%
- 10 years+22.1%/year · +639.4%
- 20 years+19.6%/year · +3481.0%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-11-17). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in HALO's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Halozyme Therapeutics Inc.'s 10-year return?
- Over the last 10 years, Halozyme Therapeutics Inc. (HALO) returned about +22.1% a year annualized (+639.4% cumulative total return).
- What is Halozyme Therapeutics Inc.'s 20-year annualized return?
- Over the last 20 years, Halozyme Therapeutics Inc. (HALO) compounded at about +19.6% a year (+3481.0% cumulative).
- What is Halozyme Therapeutics Inc.'s return since inception?
- Since 2004, Halozyme Therapeutics Inc. (HALO) has compounded at about +14.7% a year — +2158.1% in total.
